Amin-Hanjani Sepideh, Butler William E, Ogilvy Christopher S, Carter Bob S, Barker Fred G
Neurosurgical Service, Massachusetts General Hospital, and Department of Surgery Neurosurgery, Harvard Medical School, Boston, Massachusetts, USA.
J Neurosurg. 2005 Nov;103(5):794-804. doi: 10.3171/jns.2005.103.5.0794.
The authors assessed the results of extracranial-intracranial (EC-IC) bypass surgery in the treatment of occlusive cerebrovascular disease and intracranial aneurysms in the US between 1992 and 2001 by using population-based methods.
This is a retrospective cohort study based on data from the Nationwide Inpatient Sample (Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality, Rockville, MD). Five hundred fifty-eight operations were performed at 158 hospitals by 115 identified surgeons. The indications for surgery were cerebral ischemia in 74% of the operations (2.4% mortality rate), unruptured aneurysms in 19% of the operations (7.7% mortality rate), and ruptured aneurysms in 7% of the operations (21% mortality rate). Overall, 4.6% of the patients died and 4.7% of the patients were discharged to long-term facilities, 16.4% to short-term facilities, and 74.2% to their homes. The annual number of admissions in the US increased from 190 per year (1992-1996) to 360 per year (1997-2001), whereas the mortality rates increased from 2.8% (1992-1996) to 5.7% (1997-2001). The median annual number of procedures was three per hospital (range one-27 operations) or two per surgeon (range one-21 operations). For 29% of patients, their bypass procedure was the only one recorded at their particular hospital during that year; for these institutions the mean annual caseload was 0.4 admissions per year. For 42% of patients, their particular surgeon performed no other bypass procedure during that year. Older patient age (p < 0.001) and African-American race (p = 0.005) were risk factors for adverse outcome. In a multivariate analysis in which adjustments were made for age, sex, race, diagnosis, admission type, geographic region, medical comorbidity, and year of surgery, high-volume hospitals less frequently had an adverse discharge disposition (odds ratio 0.54, p = 0.03).
Most EC-IC bypasses performed in the US during the last decade were performed for occlusive cerebrovascular disease. Community mortality rates for aneurysm treatment including bypass procedures currently exceed published values from specialized centers and, during the period under study, the mortality rates increased with time for all diagnostic subgroups. This technically demanding procedure has become a very low-volume operation at most US centers.
作者采用基于人群的方法评估了1992年至2001年间美国颅外-颅内(EC-IC)搭桥手术治疗闭塞性脑血管疾病和颅内动脉瘤的结果。
这是一项基于全国住院患者样本(医疗保健成本和利用项目,医疗保健研究与质量局,马里兰州罗克维尔)数据的回顾性队列研究。115名确定的外科医生在158家医院进行了558例手术。手术指征为74%的手术是脑缺血(死亡率2.4%),19%的手术是未破裂动脉瘤(死亡率7.7%),7%的手术是破裂动脉瘤(死亡率21%)。总体而言,4.6%的患者死亡,4.7%的患者出院后入住长期护理机构,16.4%入住短期护理机构,74.2%回家。美国每年的入院人数从每年190例(1992 - 1996年)增加到每年360例(1997 - 2001年),而死亡率从2.8%(1992 - 1996年)增加到5.7%(1997 - 2001年)。每家医院每年手术例数的中位数为3例(范围1 - 27例手术)或每位外科医生每年2例(范围1 - 21例手术)。对于29%的患者,他们的搭桥手术是当年其所在特定医院记录的唯一手术;对于这些机构,每年的平均病例数为0.4例入院。对于42%的患者,其特定的外科医生在当年未进行其他搭桥手术。患者年龄较大(p < 0.001)和非裔美国人种族(p = 0.005)是不良结局的危险因素。在一项对年龄、性别、种族、诊断、入院类型、地理区域、合并症和手术年份进行调整的多变量分析中,高手术量医院不良出院处置的情况较少(比值比0.54,p = 0.03)。
过去十年在美国进行的大多数EC-IC搭桥手术是用于治疗闭塞性脑血管疾病。包括搭桥手术在内的动脉瘤治疗的社区死亡率目前超过了专业中心公布的值,并且在研究期间,所有诊断亚组的死亡率都随时间增加。这种技术要求高的手术在大多数美国中心已成为一种手术量非常低的手术。